MedTrace Logo

Impact of Virtual Reality Pelvic Floor Training on Postpartum Stress Urinary Incontinence

NCT07455838 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-03-06

No results posted yet for this study

Summary

This study will be conducted to determine the effect of virtual reality (VR) on pelvic floor training on postpartum stress urinary incontinence (SUI) .

Conditions

  • Stress Urinary Incontinence

Interventions

OTHER

Pelvic floor muscle rehabilitation supported by an immersive VR

The VR intervention, known as the VR Personality Project, will be delivered using an adjustable virtual reality headset equipped with integrated audio through the head-mounted display. Each participant will use lightweight, wireless Bluetooth controllers to engage and interact with the virtual environment. The Intervention will last for 8 weeks, with training sessions conducted three times per week under physiotherapist supervision. All participants will undergo baseline assessment prior to randomization, followed by a post-intervention assessment at 8 weeks.

DRUG

Medical treatment

Duloxetine which is a serotonin-norepinephrine reuptake inhibitor (SNRI) that increases urethral sphincter tone will be used for both groups.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Afaf Mohamed Mahmoud, PhD · Ass. Professor, Cairo University

  • Elham Shahat Hassan, PhD · Lecturer, Cairo University

  • Hossam Al Din Hussein Kamel, PhD · Professor, Al-Azhar University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-10
Primary Completion
2026-05-10
Completion
2026-05-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07455838 on ClinicalTrials.gov